Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 204708

MIRVASO (BRIMONIDINE TARTRATE)
EQ 0.33% BASE Marketing Status: Prescription

Active Ingredient: BRIMONIDINE TARTRATE
Proprietary Name: MIRVASO
Dosage Form; Route of Administration: GEL; TOPICAL
Strength: EQ 0.33% BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N204708
Product Number: 001
Approval Date: Aug 23, 2013
Applicant Holder Full Name: GALDERMA LABORATORIES LP
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English